Moderna

Filed a patent for "c-met binding antibodies, nucleic acids encoding same, and methods of use" on Mon, August 21, 2023

Filed a patent for "c-met binding antibodies, nucleic acids encoding same, and methods of use" on Mon, October 30, 2023

Filed a patent for "varicella-zoster virus mrna vaccine" on Fri, August 4, 2023

Filed a patent for "varicella-zoster virus mrna vaccine" on Mon, August 7, 2023

Filed a patent for "vlp enteroviral vaccines" on Fri, July 28, 2023

Filed a patent for "varicella zoster virus (vzv) vaccine" on Thu, February 6, 2025

Filed a patent for "mers-cov mrna vaccines" on Fri, July 14, 2023

Filed a patent for "compounds and compositions for delivery of therapeutic agents" on Wed, June 14, 2023

Filed a patent for "sars-cov-2 t cell vaccines" on Thu, June 22, 2023

Filed a patent for "sars-cov-2 t cell vaccines" on Fri, September 15, 2023

Filed a patent for "lipid nanoparticles and polynucleotides encoding extended serum half-life interleukin-22 for the treatment of metabolic disease" on Fri, December 16, 2022

Filed a patent for "small nuclear ribonucleoprotein 13 polypeptides, polynucleotides, and uses thereof" on Thu, December 22, 2022

Filed a patent for "epstein-barr virus mrna vaccines" on Mon, January 30, 2023

Filed a patent for "compositions of mrna-encoded il-15 fusion proteins and methods of use thereof for treating cancer" on Fri, February 24, 2023

Filed a patent for "lipid nanoparticles and polynucleotides encoding galactose-1-phosphate uridylyltransferase (galt) for the treatment of galactosemia" on Mon, February 27, 2023

Filed a patent for "nucleic acid influenza vaccines and respiratory virus combination vaccines" on Fri, March 10, 2023

Filed a patent for "polynucleotides encoding relaxin for the treatment of heart failure" on Tue, March 21, 2023

Filed a patent for "peg targeting compounds for delivery of therapeutics" on Thu, March 23, 2023

Filed a patent for "peg targeting compounds for delivery of therapeutics" on Thu, March 23, 2023

Filed a patent for "peg targeting compounds for delivery of therapeutics" on Thu, March 23, 2023

Filed a patent for "nucleic acid molecules encoding bi-specific secreted engagers and uses thereof" on Mon, March 27, 2023

Filed a patent for "cd16-binding antibodies and uses thereof" on Mon, March 27, 2023

Filed a patent for "myeloma antigen-binding antibodies and uses thereof" on Mon, March 27, 2023

Filed a patent for "circular mrna and production thereof" on Thu, March 30, 2023

Filed a patent for "lyme disease vaccines" on Mon, April 10, 2023